These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 11495282)

  • 1. Biochemical mechanism of combined effect of ethambutol and sparfloxacin against Mycobacterium smegmatis.
    Kaur D; Verma I; Khuller GK
    Indian J Exp Biol; 2001 Mar; 39(3):238-42. PubMed ID: 11495282
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biochemical effects of sparfloxacin on cell envelope of mycobacteria.
    Kaur D; Verma I; Khuller GK
    Indian J Biochem Biophys; 2001 Aug; 38(4):235-40. PubMed ID: 11811618
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro, ex-vivo and in vivo activities of ethambutol and sparfloxacin alone and in combination against mycobacteria.
    Kaur D; Khuller GK
    Int J Antimicrob Agents; 2001 Jan; 17(1):51-5. PubMed ID: 11137649
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro activity of C-8-methoxy fluoroquinolones against mycobacteria when combined with anti-tuberculosis agents.
    Lu T; Drlica K
    J Antimicrob Chemother; 2003 Dec; 52(6):1025-8. PubMed ID: 14613961
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of ethambutol on the phospholipids of ethambutol susceptible and resistant strains of Mycobacterium smegmatis ATCC 607.
    Sareen M; Khuller GK
    Indian J Biochem Biophys; 1990 Feb; 27(1):39-42. PubMed ID: 2341164
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The proteomic response of Mycobacterium smegmatis to anti-tuberculosis drugs suggests targeted pathways.
    Wang R; Marcotte EM
    J Proteome Res; 2008 Mar; 7(3):855-65. PubMed ID: 18275136
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phospholipid composition of Mycobacterium smegmatis susceptible and resistant to antitubercular drugs.
    Kanwar K; Khuller GK
    Indian J Biochem Biophys; 1989 Jun; 26(3):166-71. PubMed ID: 2620911
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alterations in macromolecular composition and cell wall integrity by ciprofloxacin in Mycobacterium smegmatis.
    Verma I; Rohilla A; Khuller GK
    Lett Appl Microbiol; 1999 Aug; 29(2):113-7. PubMed ID: 10499299
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The combination therapy of clarithromycin and sparfloxacin for pulmonary Mycobacterium gordonae infection].
    Tomiyama Y; Maesaki S; Yong B; Higashiyama Y; Miyazaki Y; Tomono K; Tashiro T; Kohno S
    Kekkaku; 1999 May; 74(5):457-61. PubMed ID: 10386036
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The composition of cell wall skeleton and outermost lipids of Mycobacterium vaccae is modified by ethambutol treatment.
    Rumijowska-Galewicz A; Korycka-Machała M; Lisowska K; Dziadek J
    Pol J Microbiol; 2008; 57(2):99-104. PubMed ID: 18646396
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of a quantitative assay for mycobacterial endogenous arabinase and ensuing studies of arabinase levels and arabinan metabolism in Mycobacterium smegmatis.
    Dong X; Bhamidi S; Scherman M; Xin Y; McNeil MR
    Appl Environ Microbiol; 2006 Apr; 72(4):2601-5. PubMed ID: 16597963
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The novel responses of ethambutol against Mycobacterium smegmatis mc²155 Revealed by proteomics analysis.
    Jiang T; Zhan Y; Sun M; Liu S; Zang S; Ma Y; Xin Y
    Curr Microbiol; 2011 Feb; 62(2):341-5. PubMed ID: 20686769
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Establishment and drug susceptibility test of isoniazid resistant Mycobacterium smegmatis].
    Jia PP; Zhao LL; Li XY; Zhang Q; Liu ZL; Wang X; Yu LY; Zhao LX; Cen S
    Yao Xue Xue Bao; 2011 Apr; 46(4):377-82. PubMed ID: 21751489
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intrinsic resistance of Mycobacterium smegmatis to fluoroquinolones may be influenced by new pentapeptide protein MfpA.
    Montero C; Mateu G; Rodriguez R; Takiff H
    Antimicrob Agents Chemother; 2001 Dec; 45(12):3387-92. PubMed ID: 11709313
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Extracellular and intracellular activity of sparfloxacin against Mycobacterium avium complex and Mycobacterium xenopi].
    Gevaudan MJ; Bollet C; Mallet MN; de Lamballerie X; Sambuc R; de Micco P
    Pathol Biol (Paris); 1992 May; 40(5):443-9. PubMed ID: 1323093
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rifampin- or Capreomycin-Induced Remodeling of the
    Man DK; Kanno T; Manzo G; Robertson BD; Lam JKW; Mason AJ
    mSphere; 2018 Jul; 3(4):. PubMed ID: 30021876
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic characterisation of the ethambutol resistance-determining region in Mycobacterium tuberculosis: prevalence and significance of embB306 mutations.
    Perdigão J; Macedo R; Ribeiro A; Brum L; Portugal I
    Int J Antimicrob Agents; 2009 Apr; 33(4):334-8. PubMed ID: 19097862
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correlation of amino acid uptake and susceptibility to ethambutol (EMB) with phospholipid composition of EMB-sensitive and EMB-resistant strains of Mycobacterium smegmatis.
    Cheema S; Asotra S; Khuller GK
    Indian J Exp Biol; 1986 Nov; 24(11):705-9. PubMed ID: 3570371
    [No Abstract]   [Full Text] [Related]  

  • 19. [The effect of liposomes on the growth and sensitivity of Mycobacterium smegmatis to isoniazide].
    Troshkina OA; Salina EG; Sorokoumova GM; Kaprel'iants AS; Selishcheva AA
    Prikl Biokhim Mikrobiol; 2007; 43(1):47-52. PubMed ID: 17345858
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Role of carbon substrates of culture media on Mycobacterium smegmatis susceptibility to antitubercular agents].
    Shakina IuV; Troshkina OA; Petrova EE; Salina EG; Sorokoumova GM; Shvets VI; Kapel'iants AS; Selishcheva AA
    Zh Mikrobiol Epidemiol Immunobiol; 2007; (6):7-11. PubMed ID: 18277534
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.